Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Current Liabilities -----

What is the latest Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Current Liabilities ratio of NATH BIOGENES (INDIA) is - based on Mar2025 Consolidated results.
Year Current Liabilities
Mar2025-
Mar2024-
Mar2023-
Mar2022-
Mar2013-

How is Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Current Liabilities % Change
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2013 - -

Compare Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹329.9 Cr 3.3% -1.4% -23.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,324.7 Cr -1.6% 3.7% -28.2% Stock Analytics
KAVERI SEED COMPANY ₹5,929.4 Cr -3.5% 0.1% 10.9% Stock Analytics
VENKYS (INDIA) ₹2,121.8 Cr 0.7% 2% -32.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,362.7 Cr -3% -3.8% -29.8% Stock Analytics
INDO US BIOTECH ₹283.4 Cr -2.2% -6.1% -56.5% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

3.3%

-1.4%

-23.8%

SENSEX

0.5%

0.4%

-1.1%


You may also like the below Video Courses